Now Reading: Brokerages split on Apollo Hospitals after Q1 earnings
-
01
Brokerages split on Apollo Hospitals after Q1 earnings
Brokerages are divided on Apollo Hospitals after its Q1 earnings. Citi maintained a 'buy' rating with a target price of Rs 10,770, implying a 25.7% upside from the current price of Rs…
The Story in Brief
Brokerages are divided on Apollo Hospitals after its Q1 earnings. Citi maintained a 'buy' rating with a target price of Rs 10,770, implying a 25.7% upside from the current price of Rs 8,567. Morgan Stanley also remained bullish. Macquarie, however, sees downside risk, citing concerns over the pharmacy segment and margin pressures. The mixed reactions reflect differing views on the company's growth trajectory and the impact of its retail pharmacy business.
The Indian Opinion
The bull and bear cases for Apollo Hospitals both rest on the same quarter. Citi sees 26% upside; Macquarie warns of downside. Which analyst is right depends on whether you believe the hospital chain can sustain margin improvement or if the recent disappointment in its pharmacy business will deepen. The next quarterly retail-sales disclosure will settle the argument, not the target prices.
Source: ndtvprofit.com
This story was synthesised by AI from the source linked above.
